Differential vulnerability of substantia nigra and corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids

Frontiers in Human Neuroscience

Volumn , Issue AUGUST, 2012, Pages

  Cardoso, Henriqueta D ^a   Passos, Priscila P ^a   Lagranha, Claudia J ^b   Ferraz, Anete C ^c   Santos, Eraldo F ^a   Oliveira, Rafael S ^a   Oliveira, Pablo E L ^a   de Santos, Rita C F ^a   Santana, David F ^a   Borba, Juliana M C ^d   Rocha de Melo, Ana P ^d   Guedes, Rubem C A ^d   Navarro, Daniela M A F ^d   Santos, Geanne K N ^b   Borner, Roseane ^b   Picanço Diniz, Cristovam W ^e   Beltrão, Eduardo I ^a   Silva, Janilson F ^a   Rodrigues, Marcelo C A ^a   Andrade da Costa, Belmira L S ^a  

^a DEPARTAMENTO DE MICOLOGIA   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d Federal University of Pernambuco   (Brazil)

^e FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Catalase; Corpus striatum; DHA; Lipid peroxidation; Neurodegeneration; Oxidative stress; Substantia nigra; Superoxide dismutase

Indexed keywords

CATALASE; DOCOSAHEXAENOIC ACID; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; FATTY ACID ANALYSIS; FEMALE; LIPID PEROXIDATION; MALE; NERVE CELL DEGENERATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; RAT; SUBSTANTIA NIGRA; WISTAR RAT;

EID: 85171923981     PISSN: None     EISSN: 16625161     Source Type: Journal    
DOI: 10.3389/fnhum.2012.00249     Document Type: Article

References (55)

1. Aebi, H. (1984). Catalase in vitro. Methods Enzymol. 105, 121-126.
2. Ahmad, S. O., Park, J. H., Radel, J. D., and Levant, B. (2008). Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study. Neurosci. Lett. 438, 303-307.
3. Berry, J. F., Cevallos, W. H., and Wade, R. R. (1965). Lipid class and fatty acid composition of intact peripheral nerve and during Wallerian degeneration. J. Am. Oil Chem. Soc. 42, 492-500.
4. Bian, G. L., Wei, L. C., Shi, M., Wang, Y. Q., Cao, R., and Chen, L. W. (2007). Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1 2 3, 6-tetrahydro pyridine-treated C57BL/6 mice. Brain Res. 30, 55-61.
5. Borba, J. M. C., Rocha-de-Melo, A. P., Amâncio dos Santos, A., Andrade da Costa, B. L. S., and Silva, R. P. (2010). Essential fatty acid deficiency reduces cortical spreading depression propagation in rats: a two-generation study. Nutr. Neurosci. 13, 144-150.
6. Bourre, J. M., Piciotti, M., Dumont, O., Pascal, G., and Durand, G. (1990). Dietary linoleic acid and polyunsat-urated fatty acids in rat brain and other organs: minimal requirements of linoleic acid. Lipids 25, 465-472.
7. Bousquet, M., Gibrat, C., Saint-Pierre, M., Julien, C., and Calon, F. (2009). Modulation of brain-derived neu-rotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 1401-1408.
8. Bousquet, M., Saint-Pierre, M., Julien, C., Salem, N. Jr., and Cicchetti, F. (2008). Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J. 22, 1213-1225.
9. Brenna, J. T., and Diau, G. Y. (2007). The influence of dietary docosahex-aenoic acid and arachidonic acid on central nervous system polyun-saturated fatty acid composition. Prostaglandins Leukot. Essent. Fatty Acids 77, 247-250.
10. Cansev, M., Ulus, I. H., Wang, L., Maher, T. J., and Wurtman, R. J. (2008). Restorative effects of uri-dine plus docosahexaenoic acid in a rat model of Parkinson's disease. Neurosci. Res. 62, 206-209.
11. Delattre, A. M., Kiss, A., Szawka, R. E., Anselmo-Franci, J. A., Bagatini, P. B., Xavier, L. L., Rigon, P., Achaval, M., Iagher, F., de David, C., Marroni, N. A., and Ferraz, A. C. (2010). Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease. Neurosci. Res. 66, 256-264.
12. Deuel, H. J., Alfin-Slater Jr, E. B., Wells, A. F., Krydeh, G. D., and Aftergood, L. (1954). The effect of fat level of the diet on general nutrition. XIV. Further studies of the effect of hydrogenated coconut oil on essential fatty acid deficiency in the Rat. J. Nutr. 55, 337-346.
13. Ehara, A., and Ueda, S. (2009). Application of fluoro-jade C in acute and chronic neurodegenera-tion models: utilities and staining differences. Acta Histochem. Cytochem. 42, 171-179.
14. Fedorova, I., and Salem, N. Jr. (2006). Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot. Essent. Fatty Acids 75, 271-289.
15. Floor, E., and Wetzel, M. G. (1998). Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 70, 268-275.
16. Folch, J., Lees, M., and Sloane Stanley, G. H. (1957). A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509.
17. Glozman, S., Green, P., and Yavin, E. (1998). Intraamniotic ethyl docosa-hexaenoate administration protects fetal rat brain from ischemic stress. J. Neurochem. 70, 2484-2491.
18. Green, P., Glozman, S., Weiner, L., and Yavin, E. (2001). Enhanced free radicals scavenging and decreased lipid peroxidation in the rat fetal brain after treatment with ethyl-docosahexaenoate. Biochim. Biophys. Acta 1532, 203-212.
19. Hargrave, K. M., Azain, M. J., and Miner, J. L. (2005). Dietary coconut oil increases conjugated linoleic acid-induced body fat loss in mice independent of essential fatty acid deficiency. Biochim. Biophys. Acta 1737, 52-60.
20. Hashimoto, M., and Hossain, S. (2011). Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahex-aenoic acid on cognitive decline in Alzheimer's disease. J. Pharmacol. Sci. 116, 150-162.
21. Igarashi, M., Gao, F., Kim, H. W., Ma, K., Bell, J. M., and Rapoport, S. I. (2009). Dietary n-6 PUFA deprivation for 15 weeks reduces arachi-donic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats. Biochim. Biophys. Acta 132-139.
22. Jenner, P., Dexter, D. T., and Sian, J. (1992). Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The royal kings and queens Parkinson's disease research group. Ann. Neurol. 32(Suppl.), S82-S87.
23. Juaneda, P., and Rocquelin, G. (1985). Rapid and convenient separation of phospholipids and nonphosphorus lipids from rat heart using silica cartridges. Lipids 20, 40-41.
24. Kidd, P. M. (2000). Parkinson's disease as multifactorial oxidative neuro degeneration: implications for integrative management. Altern. Med. Rev. 5, 502-545.
25. Kitajka, K., Sinclair, A. J., Weisinger, R. S., Weisinger, H. S., and Mathai, M. (2004). Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc. Natl. Acad. Sci. U.S.A. 101, 10931-10936.
26. Kohen, R., and Nyska, A. (2002). Invited review: oxidation of biological systems: oxidative stress phenomena, anti-oxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 30, 620-650.
27. Kolosova, N. G., Shcheglova, T. V., Amstislavskaya, T. G., and Loskutova, L. V. (2003). Comparative analysis of LPO products in brain structures of Wistar and OXYS rats of different age. Bull. Exp. Biol. Med. 135, 593-596.
28. Kuperstein, F., Eilam, R., and Yavin, E. (2008). Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n-3 fatty acid dietary deficiency. J. Neurochem. 106, 662-671.
29. Lapillonne, A., Clarke, S. D., and Heird, W. C. (2004). Polyunsaturated fatty acids and gene expression, Curr. Opin. Clin. Nutr. Metab. Care 2, 151-156.
30. Li, L. H., Qin, H. Z., Wang, J. L., Wang, J., Wang, X. L., and Gao, G. D. (2009). Axonal degeneration of nigra-striatum dopaminer-gic neurons induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in mice. J. Int. Med. Res. 37, 455-463.
31. Ling, P. R., De Leon, C. E., Le, H., Puder, M., and Bistrian, B. R. (2010). Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated coconut oil diet. Prostaglandins Leukot. Essent. Fatty Acids 83, 229-237.
32. Marcheselli, V. L., Hong, S., and Lukiw, W. J. (2003). Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278, 43807-43817.
33. Mayurasakorn, K., Williams, J. J., Ten, V. S., and Deckelbaum, R. J. (2011). Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia. Curr. Opin. Clin. Nutr. Metab. Care 14, 158-167.
34. Melo, A., Monteiro, L., Lima, R. M., Oliveira, D. M., Cerqueira, M. D., and El-Bachá, R. S. (2011). Oxidative stress in neurodegenera-tive diseases: mechanisms and therapeutic perspectives. Oxid. Med. Cell. Longev. 2011, 14.
35. Misra Hara, P., and Fridovich, I. (1972). The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superox-ide dismutase. J. Biol. Chem. 247, 3170-3175.
36. Miyazawa, D., Yasui, Y., Yamada, K., Ohara, N., and Okuyama, H. (2010). Regional differences of the mouse brain in response to an α-linolenic acid-restricted diet: neurotrophin content and protein kinase activity. Life Sci. 87, 490-494.
37. Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., and Bazan, N. G. (2004). Neuroprotectin D1, a docosahexaenoic acid derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 101, 8491-8496.
38. Mythri, R. B., Venkateshappa, C., Harish, G., Mahadevan, A., Muthane, U. B., Yasha, T. C., Bharath, M. M. S., and Shankar, S. K. (2011). Evaluation of markers of oxidative stress, anti-oxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains. Neurochem. Res. 36, 1452-1463.
39. Ohkawa, H., Ohishi, N., and Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
40. Ozsoy, O., Tanriover, G., Derin, N., Uysal, N., and Demir, N. (2011). The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B. Neurotox. Res. 20, 250-262.
41. Pan, H. C., Kao, T. K., Ou, Y. C., Yang, D. Y., Yen, Y. J., Wang, C. C., Chuang, Y. H., Liao, S. L., Raung, S. L., Wu, C. W., Chiang, A. N., and Chen, C. J. (2009). Protective effect of docosahexaenoic acid against brain brain injury in ischemic rats. J. Nutr. Biochem. 20, 715-725.
42. Passos, P. P., Borba, J. M. C., Rocha de Melo, A. P., Guedes, R. C. A., Silva, R. P., Melo Filho, W. T., Gouveia, K. M. M., Navarro, D. M. A. F., Santos, G. K. N., Borner, R., Picanço-Diniz, C. W., Pereira, A. Jr., Costa, M. S. M. O., Rodrigues, M. C. A., and Andrade-da-Costa, B. L. S. (2012). Dopaminergic cell populations of the rat substantia nigra are differentially affected by essential fatty acid dietary restriction over two generations. J. Chem. Neuroanat. 44, 66-75.
43. Paxinos, G., and Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates. California: Academic Press Inc.
44. Rotstein, N. P., Politi, L. E., German, O. L., and Girotti, R. (2003). Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest. Ophthalmol. Vis. Sci. 44, 2252-2259.
45. Sarsilmaz, M., Songur, A., Ozyurt, H., Kuş, I., Ozen, O. A., Ozyurt, B., Söǧüt, S., and Akyol, O. (2003). Potential role of dietary omega-3 essential fatty acids on some oxidant/anti-oxidant parame-ters in rats' corpus striatum. Prostaglandins Leukot. Essent. Fatty Acids 69, 253-259.
46. Sayre, L. M., Smith, M. A., and Perry, G. (2001). Chemistry and biochemistry of oxidative stress in neu-rodegenerative disease. Curr. Med. Chem. 8, 721-738.
47. Schmitz, G., and Ecker, J. (2008). The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 47, 147-155.
48. Soares, M. C., Aléssio, M. L., Léger, C. L., Bluet-Pajot, M. T., and Clauser, H. (1995). Effect of essential fatty acid deficiency on membrane fatty acid content and growth hormone stimulation of rat pituitaries during postnatal development. J. Lipid Res. 36, 1401-1406.
49. Thomas, B., and Beal, M. F. (2007). Parkinson's disease. Hum. Mol. Genet. 2, 183-194.
50. Tian, C., Fan, C., Liu, X., Xu, F., and Qi, K. (2011). Brain his-tological changes in young mice submitted to diets with different ratios of n-6/n-3 polyunsaturated fatty acids during maternal pregnancy and lactation. Clin. Nutr. 30, 659-667.
51. Venkateshappa, C., Harish, G., Mythri, R. B., Mahadevan, A., Srinivas Bharath, M. M., and Shankar, S. K. (2012). Increased oxidative damage and decreased anti-oxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease. Neurochem. Res. 37, 358-369.
52. Wang, X., and Michaelis, E. K. (2010). Selective neuronal vulnerability to oxidative stress in the brain. Front. Aging Neurosci. 2:12. doi: 10.3389/fnagi.2010.00012
53. Yang, L., Shah, K., Wang, H., Karamyan, V. T., and Abbruscato, T. J. (2011). Characterization of neuroprotective effects of biphalin, an opioid receptor agonist, in a model of focal brain ischemia. J. Pharmacol. Exp. Ther. 339, 499-508.
54. Yavin, E. (2006) Docosahexaenoic acid: a pluripotent molecule acting as a membrane fluidizer, a cellular anti-oxidant and a modulator of gene expression. Nutr. Health 18, 261-262.
55. Zhang, W., Li, P., Hu, X., Zhang, F., Chen, J., and Gao, Y. (2011). Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection. Front. Biosci. 17, 2653-2670.